Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Dr Reddy

      Dr Reddy's Laboratories in process to seek permission for launch of 70 products in China

      Farhat Nasim3 Jun 2019 11:00 AM IST
      Dr Reddy's Chief Operations Officer, Erez Israeli in a recent earnings call said the drug-maker is in the process of seeking necessary approvals from...
      DTAB sub-committee to evaluate Fixed Dose Combination drugs considered irrational

      DTAB sub-committee to evaluate Fixed Dose Combination drugs considered irrational

      Farhat Nasim2 Jun 2019 2:40 PM IST
      New Delhi: The fate of Fixed Dose combinations considered irrational by the government have fallen once again in limelight as the Drugs Technical...
      Theranica wins USFDA nod for smartphone controlled migraine relief wearable device

      Theranica wins USFDA nod for smartphone controlled migraine relief wearable device

      Farhat Nasim31 May 2019 9:25 AM IST
      Nerivio Migra, a first-in-category product, is placed on the upper arm (not the head or neck) and uses smartphone-controlled electronic pulses to...
      Sun Pharma Whole Time Director Sudhir Valia steps down from executive role

      Sun Pharma Whole Time Director Sudhir Valia steps down from executive role

      Farhat Nasim30 May 2019 10:00 AM IST
      Earlier in January 2019, Sun Pharma had said that it had not given any loans nor guarantees to Suraksha Realty, a company in which Sudhir Valia is one...
      ResMed appoints Shubhi Khurana as New India, South Asia General Manager; to help increase awareness about sleep apnea

      ResMed appoints Shubhi Khurana as New India, South Asia General Manager; to help increase awareness about sleep apnea

      Farhat Nasim30 May 2019 9:30 AM IST
      Shubhi Khurana has more than two decades of experience in the pharmaceutical, healthcare, and medtech industries in various leadership roles.NEW...
      Technical Committee recommends CDSCO to approve import, marketing of Sanofi TB drug with clinical trial waiver

      Technical Committee recommends CDSCO to approve import, marketing of Sanofi TB drug with clinical trial waiver

      Farhat Nasim28 May 2019 4:21 PM IST
      New Delhi: Apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has been recommended by the Techincal Committee to granted...
      Granules India gets USFDA nod for Methylphenidate Hydrochloride ER capsules

      Granules India gets USFDA nod for Methylphenidate Hydrochloride ER capsules

      Farhat Nasim28 May 2019 10:00 AM IST
      The approved product, Methylphenidate Hydrochloride extended-release capsules, is bioequivalent to the reference listed drug product (RLD), Ritalin LA...
      Novartis wins USFDA approval for first PI3K inhibitor for breast cancer

      Novartis wins USFDA approval for first PI3K inhibitor for breast cancer

      Farhat Nasim27 May 2019 6:10 PM IST
      The drug, alpelisib, to be marketed under the brand name Piqray, belongs to a class of drugs known as PI3K inhibitors and is the first of its kind to...
      Glenmark Pharma gets USFDA nod for Aspirin, extended-release Dipyridamole capsules

      Glenmark Pharma gets USFDA nod for Aspirin, extended-release Dipyridamole capsules

      Farhat Nasim27 May 2019 10:00 AM IST
      Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Aspirin and...
      Lupin gets couple of USFDA observations for Goa plant

      Lupin gets couple of USFDA observations for Goa plant

      Farhat Nasim27 May 2019 9:45 AM IST
      Lupin, however, said it does not believe that the classification would have an impact on the disruption of supplies or the existing revenues from...
      Woman arrested at Delhi airport for smuggling growth hormone worth Rs 32 lakh

      Woman arrested at Delhi airport for smuggling 'growth hormone' worth Rs 32 lakh

      Farhat Nasim26 May 2019 9:30 AM IST
      A detailed personal and baggage search of the passenger resulted in the recovery of Zptropin anSomatropin medicines having total market value of Rs...
      Merck Ebola vaccine in demand rather than JnJ rival drug

      Merck Ebola vaccine in demand rather than JnJ rival drug

      Farhat Nasim26 May 2019 9:26 AM IST
      Merck's licensing process is underway but it was unclear how long it would take, he said. Congo's government had not discussed or requested the...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok